Journal article

Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study

Kwok-Leung Ong, Rachel O'Connell, Andrzej S Januszewski, Alicia J Jenkins, Aimin Xu, David R Sullivan, Philip J Barter, Russell S Scott, Marja-Riitta Taskinen, Boris Waldman, Peter G Colman, James D Best, John R Simes, Kerry-Anne Rye, Anthony C Keech

Clinical Chemistry | OXFORD UNIV PRESS INC | Published : 2017

Grants

Awarded by National Heart Foundation of Australia


Awarded by NSW CVRN Research Development Project from the National Heart Foundation of Australia


Awarded by National Health and Medical Research Council (NHMRC) of Australia


Awarded by NHMRC Career Development Fellowship


Awarded by NHMRC


Funding Acknowledgements

The measurement of FGF21 concentrations in the FIELD samples was supported by a Grant-in-Aid (G 12S 6681) and the NSW CVRN Research Development Project Grant (100715) both from the National Heart Foundation of Australia. K.L. Ong, Program grants (482800 & 1037903) from the National Health and Medical Research Council (NHMRC) of Australia, Vice-Chancellor's Postdoctoral Fellowship from the University of New South Wales, and the NHMRC Career Development Fellowship (1122854). A.C. Keech, NHMRC Program grant (1037786) and Fellowship grant (1024105). Expert Testimony: None declared.